#PhRMA12: Gearing Up and Getting Ready

#PhRMA12: Gearing Up and Getting Ready

04.12.12 | By Kate Connors

We've traveled north to Boston for PhRMA's Annual Meeting, which begins today. My excellent colleague Christian has been doing some interviews leading up to our meeting and giving details about how to engage, but I wanted to give you all a reminder that our Website will be a great resource for those of you who aren't going to be able to join us. For example, we'll be streaming our wide array of interesting panels live. And if you can't watch from your desks, I'm going to be stepping into my old journalist shoes and writing articles like crazy about the great commentary provided by our speakers. And of course, you can always follow the ongoing discussion on Twitter at #PhRMA12.

There's going to be a lot that's worth hearing. For example, Thursday afternoon, at 2 pm, panelists will discuss how rare disease research has evolved over the years to help yield new treatment options for patients living with these challenging diseases. The panel will feature Steve Gibson, chief public policy officer for the ALS Association, Aaron Kesselheim, MD, JD, assistant professor of medicine at Harvard Medical School, and Genzyme President and CEO David Meeker. This panel will be moderated by the always engaging Mike Huckman, senior vice president of MSLGROUP Healthcare.

Friday morning at 8:15, panelists will discuss opportunities to provide better care to patients in emerging markets. This conversation will feature Samir Khalil, executive director of public policy at Merck & Co., Scott Minick, President and CEO of BIND Biosciences, and David Taylor, professor of pharmaceutical and public health policy at the University of London's UCL School of Pharmacy. The moderator will be BBC World North America's Washington Correspondent Katty Kay.

So get ready to follow along through whichever means works best for you, and definitely join in the dialogue!

Follow Kate on Twitter @KateAtPhRMA

More On PhRMA — powered by PhRMApedia


Cost in Context